Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 22 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06972615
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- BLATAM CABA, Argentina
NCT07602010
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Oslo University Hospital Oslo, Norway
NCT07283835
- Conditions
- Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
- Locations
-
- Peking University First Hospital (First Clinical Medical School of Peking University) Beijing, Beijing Municipality, China
- Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
- Conditions
- Carcinoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Syndrome, +18 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029 Nanjing, Jiangsu, China
NCT06663137
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Relmada Site Raanana, Israel
NCT06287541
- Conditions
- Carcinoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Syndrome, +18 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT06167356
- Conditions
- Bladder Cancer, Bladder Cancer Recurrent, Bladder Cancer Stage I, With Cancer in Situ, +22 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
Not Yet Recruiting
Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?
NCT07625527
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +14 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, China
- General Hospital of Tianjin Medical University Tianjin, China
- Tianjin Hospital Tianjin, China
- Xingtai People's Hospital Xingtai, China
Not Yet Recruiting
Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients
NCT07231809
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma in Situ of Bladder, +16 more
- Locations
-
- P.O. "Santa Maria delle Grazie" - ASL Napoli 2 Nord Pozzuoli, Italy
Not Yet Recruiting
Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial
NCT07198451
- Conditions
- Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
- Locations
-
Not specified
NCT05945108
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
- Locations
-
- Research Site Belo Horizonte, Brazil
- Research Site Porto Alegre, Brazil
- Research Site Recife, Brazil
- Research Site Salvador, Brazil
Completed
Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)
NCT06767982
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Ankara University Faculty of Medicine Ibni Sina Hospital Ankara, Altindag, Turkey (Türkiye)
NCT04387461
- Conditions
- Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
- Locations
-
- University of California - San Diego La Jolla, California, United States
- University of California - Irvine Orange, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern University Tampa, Florida, United States
NCT06205277
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
- Locations
-
- University of Trieste - Azienda Ospedaliera Universitaria Giuliano Isontina Trieste, Friuli Venezia Giulia, Italy
NCT06020807
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Urology San Antonio San Antonio, Texas, United States
NCT01004211
- Conditions
- Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
- Locations
-
- National Institute for Cancer Research (IST) Genoa, Italy
- Centro Urologico di Eccellenza ASL 1 Imperia, Italy
NCT01731652
- Conditions
- Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
- Locations
-
- BCG Oncology Phoenix, Arizona, United States
- The Urology Center of Colorado Denver, Colorado, United States
- Urologic Consultants of SE PA Bala-Cynwyd, Pennsylvania, United States
- Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
NCT02343614
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
Active, Not Recruiting
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT04452591
- Conditions
- Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
- Locations
-
- Urology Centers Alabama Homewood, Alabama, United States
- BCG Oncology Phoenix, Arizona, United States
- Mayo Clinic Cancer Center Phoenix, Arizona, United States
- Arizona Institute of Urology Tucson, Arizona, United States
Active, Not Recruiting
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
NCT06111235
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Urology Centers of Alabama PC Homewood, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Scottsdale, Arizona, United States
- Arizona Institute of Urology PLLC Tucson, Arizona, United States